Original Paper
. The effect of ciprofloxacin on the biofilm produced by the antibiotic-susceptible C. striatum strain was evaluated using three concentrations of the antimicrobial agent (2 ×, 4 ×, and 6 × the MIC – the Minimum Inhibitory Concentration). The basis for the interpretation of results was the statistical analysis of maximum points readings from the surface comprising a total of 245 areas of the biofilm image under the confocal microscope. It was observed that ciprofloxacin at a concentration equal to 4
ALINA OLENDER,
AGNIESZKA BOGUT,
AGNIESZKA MAGRYŚ,
KATARZYNA KRÓL-TURMIŃSKA
Polish Journal of Microbiology , ISSUE 4, 431–440
mini-review
prevalence of resistant E. coli (< 20%) (Bartoletti et al. 2016; Bonkat et al. 2017). Fluoroquinolones (ciprofloxacin and levofloxacin) play an important role in the treatment of more severe infections and septicemia, and thus, ciprofloxacin should be considered as an alternative, not as a first-line antibiotic, in the treatment of uncomplicated cystitis (Bartoletti et al. 2016). Ciprofloxacin could be used as second-line empiric therapy in cases of mild and moderate pyelonephritis or complicated UTI
BARBARA KOT
Polish Journal of Microbiology , ISSUE 4, 403–415
Original Paper
= 0.017), amikacin (61.1% vs. 90.7%; p = 0.001), gentamicin (70.0% vs. 93.2%; p = 0.002), cefalexin (41.2% vs. 83.3%; p < 0.001), cefotaxime (63.6% vs. 89.4%; p = 0.002), ceftazidime (61.9% vs. 85.6%; p = 0.008), cefepime (73.7% vs. 91.1%; p = 0.025), ciprofloxacin (54.1% vs. 72.2%; p = 0.024) and norfloxacin (40.5% vs. 62.5%; p = 0.011) among patients with catheter-associated UTI (CAUTI) compared to those with non-CAUTI. A similar susceptibility profile was observed between different age groups
MIKOŁAJ MICHNO,
ANTONI SYDOR,
MARTA WAŁASZEK,
WŁADYSŁAW SUŁOWICZ
Polish Journal of Microbiology , ISSUE 4, 517–524
original-paper
, Streptococcus pyogenes, Streptococcus pneumoniae and Enterococcus faecalis. Its activity against these organisms is regarded to be superior to other fluoroquinolones as ciprofloxacin, moxifloxacin, and gemifloxacin (Park et al. 2006; Karpiuk and Tyski 2013). Zabofloxacin is slightly inferior in comparison with other fluoroquinolones against Enterobacteriaceae family. However, it is effective against the Gram-negative respiratory bacteria, such as Haemophilus influenzae and Moraxella catarrhalis (Karpiuk and
NELLY M. MOHAMED,
AZZA S. ZAKARIA,
EVA A. EDWARD,
AMANY ABDEL-BARY
Polish Journal of Microbiology , ISSUE 1, 59–69